Patent 9982303 was granted and assigned to CHILDREN'S HOSPITAL MEDICAL CENTER on May, 2018 by the United States Patent and Trademark Office.
The disclosure provides methods and compositions for diagnosing a patient eosinophilic esophagitis, the methods based upon the patient's gene expression profile for a panel of genes. The methods can also be used to exclude a diagnosis of chronic esophagitis.